Insulet Corporation vs Zocdoc

Side-by-side comparison of AI visibility scores, market position, and capabilities

Zocdoc leads in AI visibility (86 vs 77)
Insulet Corporation logo

Insulet Corporation

LeaderHealthcare Tech

Enterprise

Acton MA tubeless insulin pump (NASDAQ: PODD) $2.18B FY2024 revenue (+21%); Omnipod 5 automated insulin delivery with Dexcom/Libre integration, type 2 expansion, competing with Medtronic MiniMed and Tandem.

AI VisibilityBeta
Overall Score
B77
Category Rank
#46 of 596
AI Consensus
87%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
78
Gemini
77

About

Insulet Corporation is an Acton, Massachusetts-based medical device company — publicly traded on the NASDAQ (NASDAQ: PODD) as an S&P 500 Health Care component — developing, manufacturing, and commercializing the Omnipod insulin delivery system: a tubeless, wearable, waterproof insulin pump patch worn directly on the body without tubing connections to a separate controller, automatically delivering insulin to people with type 1 and type 2 diabetes through approximately 5,000 employees globally. In fiscal year 2024, Insulet reported revenues of $2.18 billion (+21% year-over-year), driven by Omnipod 5 (Omnipod's automated insulin delivery — AID — system integrating with Dexcom CGM and Abbott FreeStyle Libre sensors to automatically adjust insulin delivery based on real-time glucose readings without manual user input), which drove international expansion in Europe and adoption in type 2 diabetes patients who previously used multiple daily injections rather than insulin pumps. CEO Jim Hollingshead has accelerated Omnipod's differentiation through the automated insulin delivery positioning: Omnipod 5's algorithm automatically modulates basal insulin rates every 5 minutes based on continuous glucose monitor readings — reducing A1c levels and time-in-hypoglycemia without requiring the user to manually program correction boluses for most scenarios — transforming diabetes management from active self-management to a background automated process that dramatically improves quality of life for insulin-dependent diabetics.

Full profile
Zocdoc logo

Zocdoc

GrowthHealthTech

Patient Scheduling Marketplace

Zocdoc is a patient appointment booking marketplace that lets patients find and book in-network doctors in real time, with insurance verification and same-day availability filters.

AI VisibilityBeta
Overall Score
A86
Category Rank
#11 of 596
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
80
Gemini
92

About

Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Patients can filter by specialty, insurance plan, location, and next available appointment, then book online in seconds — eliminating the phone-tag and hold-time historically required to schedule care. The platform verifies insurance acceptance in real time and sends automated reminders to reduce no-shows.

Full profile

AI Visibility Head-to-Head

77
Overall Score
86
#46
Category Rank
#11
87
AI Consensus
70
stable
Trend
stable
78
ChatGPT
88
78
Perplexity
80
77
Gemini
92
74
Claude
92
74
Grok
86

Key Details

Category
Enterprise
Patient Scheduling Marketplace
Tier
Leader
Growth
Entity Type
company
brand

Capabilities & Ecosystem

Capabilities

Only Zocdoc
Patient Scheduling Marketplace
Insulet Corporation is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.